NBP
Price
$1.59
Change
-$0.10 (-5.92%)
Updated
Sep 11 closing price
Capitalization
185.04M
61 days until earnings call
Intraday BUY SELL Signals
VSTM
Price
$7.32
Change
-$0.30 (-3.94%)
Updated
Sep 11 closing price
Capitalization
664.28M
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NBP vs VSTM

NBP vs VSTM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NBP vs. VSTM commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBP is a Hold and VSTM is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($664M) has a higher market cap than NBP($185M). VSTM YTD gains are higher at: -5.181 vs. NBP (-60.050). NBP has higher annual earnings (EBITDA): -121.6M vs. VSTM (-199.26M). NBP has more cash in the bank: 191M vs. VSTM (136M). NBP has less debt than VSTM: NBP (4.46M) vs VSTM (84.3M). VSTM has higher revenues than NBP: VSTM (87.5M) vs NBP (0).
NBPVSTMNBP / VSTM
Capitalization185M664M28%
EBITDA-121.6M-199.26M61%
Gain YTD-60.050-5.1811,159%
P/E RatioN/AN/A-
Revenue087.5M-
Total Cash191M136M140%
Total Debt4.46M84.3M5%
FUNDAMENTALS RATINGS
NBP vs VSTM: Fundamental Ratings
NBP
VSTM
OUTLOOK RATING
1..100
6968
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6437
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VSTM's Valuation (56) in the Biotechnology industry is in the same range as NBP (82) in the null industry. This means that VSTM’s stock grew similarly to NBP’s over the last 12 months.

VSTM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NBP (100) in the null industry. This means that VSTM’s stock grew similarly to NBP’s over the last 12 months.

NBP's SMR Rating (97) in the null industry is in the same range as VSTM (100) in the Biotechnology industry. This means that NBP’s stock grew similarly to VSTM’s over the last 12 months.

VSTM's Price Growth Rating (37) in the Biotechnology industry is in the same range as NBP (64) in the null industry. This means that VSTM’s stock grew similarly to NBP’s over the last 12 months.

NBP's P/E Growth Rating (98) in the null industry is in the same range as VSTM (100) in the Biotechnology industry. This means that NBP’s stock grew similarly to VSTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NBPVSTM
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (NBP: $1.59 vs. VSTM: $7.32)
Brand notoriety: NBP and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NBP: 99% vs. VSTM: 84%
Market capitalization -- NBP: $185.04M vs. VSTM: $664.28M
NBP [@Biotechnology] is valued at $185.04M. VSTM’s [@Biotechnology] market capitalization is $664.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBP’s FA Score shows that 0 FA rating(s) are green while VSTM’s FA Score has 0 green FA rating(s).

  • NBP’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, VSTM is a better buy in the long-term than NBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBP’s TA Score shows that 5 TA indicator(s) are bullish while VSTM’s TA Score has 3 bullish TA indicator(s).

  • NBP’s TA Score: 5 bullish, 5 bearish.
  • VSTM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, NBP is a better buy in the short-term than VSTM.

Price Growth

NBP (@Biotechnology) experienced а -11.67% price change this week, while VSTM (@Biotechnology) price change was -10.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

NBP is expected to report earnings on Nov 12, 2026.

VSTM is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
NBP
Daily Signal:
Gain/Loss:
VSTM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VALSX29.130.40
+1.39%
Value Line Select Core Inv
UMPIX82.12N/A
N/A
ProFunds UltraMid Cap Inv
GSIWX34.47N/A
N/A
Goldman Sachs International Eq ESG R6
PLFPX36.84N/A
N/A
Principal Large Cap S&P 500 Index R5
TEGAX41.49N/A
N/A
Touchstone Mid Cap Growth A

NBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBP has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NBP jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBP
1D Price
Change %
NBP100%
-5.92%
VCYT - NBP
43%
Loosely correlated
-2.76%
INDP - NBP
39%
Loosely correlated
+8.20%
SLS - NBP
34%
Loosely correlated
-14.42%
VSTM - NBP
34%
Loosely correlated
-3.94%
FHTX - NBP
32%
Poorly correlated
-1.56%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with SRPT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-3.94%
SRPT - VSTM
40%
Loosely correlated
-0.34%
LXEO - VSTM
38%
Loosely correlated
-2.52%
MDGL - VSTM
37%
Loosely correlated
+0.26%
DYN - VSTM
37%
Loosely correlated
-1.14%
ZYME - VSTM
36%
Loosely correlated
-0.74%
More